|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> >> 市场分析报告 |
市场分析报告 |
|
TBG Diagnostics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... PG11047, is in Phase 1(b) clinical trials. PG545 The companys PG545 is a heparan sulfate mimetic and ... tumors, namely angiogenesis and metastasis. PG545 is its candidate from the ... PG500 series. The phase I trial of PG545 is being conducted. This compound ... Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) - Pipeline Review, H2 2018 Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) - Pipeline Review, H2 2018 SUMMARY Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 10 molecules. Out of which approximately ... Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) - Pipeline Review, H1 2018 Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) - Pipeline Review, H1 2018 SUMMARY Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 12 molecules. Out of which approximately ... Heparanase - Pipeline Review, H1 2020 Heparanase - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Heparanase - Pipeline Review, H1 2020'; Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 10 molecules. Out ... Heparanase - Drugs In Development, 2021 Heparanase - Drugs In Development, 2021 SUMMARY Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) pipeline Target constitutes close to 15 molecules. Out of which approximately 14 molecules are developed by companies and remaining by ... Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or EC 3.2.1.166) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Heparanase (Endo Glucoronidase or Heparanase 1 or HPSE or ... |